Cargando…

Prognostic value of p16, p53, and pcna in sarcoma and an evaluation of immune infiltration

BACKGROUND: p16, p53, and proliferating cell nuclear antigen (pcna) genes play significant roles in many chromatin modifications and have been found to be highly expressed in a variety of tumor tissues. Therefore, they have been used as target genes for some tumor therapies. However, the differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Dechao, Ma, Xiao, Guo, Huihui, Zhang, Haotian, Bian, Ashuai, Yu, Haoran, Cheng, Wendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185979/ https://www.ncbi.nlm.nih.gov/pubmed/35689249 http://dx.doi.org/10.1186/s13018-022-03193-3

Ejemplares similares

Diagnostic value and immune infiltration characterization of YTHDF2 as a critical m6A regulator in osteoarthritic synovitis
por: Bian, Ashuai, et al.
Publicado: (2023)

L-Glutamine alleviates osteoarthritis by regulating lncRNA-NKILA expression through the TGF-β1/SMAD2/3 signalling pathway
por: Ma, Xiao, et al.
Publicado: (2022)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

PCNA AND P53 EXPRESSION IN ORAL LEUKOPLAKIA WITH DIFFERENT DEGREES OF KERATINIZATION
por: Lawall, Melaine de Almeida, et al.
Publicado: (2006)

The prognostic value of PCNA expression in patients with osteosarcoma: A meta-analysis of 16 studies
por: Wang, Xing, et al.
Publicado: (2017)

Prognostic value of GLCE and infiltrating immune cells in Ewing sarcoma
por: Wen, Jian, et al.
Publicado: (2023)

The role of p53, PCNA and Ki–67 as outcome predictors in the treatment of laryngeal cancer
por: Sarafoleanu, D, et al.
Publicado: (2009)

p53 and PCNA Expression in Keratocystic Odontogenic Tumors Compared with Selected Odontogenic Cysts
por: Seyedmajidi, Maryam, et al.
Publicado: (2013)

Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas
por: Desai, Chandni, et al.
Publicado: (2021)

HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
por: da Costa, Allini Mafra, et al.
Publicado: (2017)

Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway
por: Lu, Zhiyan, et al.
Publicado: (2017)

Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence
por: Rana, Manjit K, et al.
Publicado: (2021)

PCNA, Ki-67, p53, bcl-2 and Prognosis in Intraoral Squamous Cell Carcinoma of the Head and Neck
por: Nylander, Karin, et al.
Publicado: (1997)

The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis
por: Xing, Xiang-Bin, et al.
Publicado: (2013)

The prognostic value of p53 mutation in pediatric marrow hypoplasia
por: Abo-Elwafa, Hasnaa A, et al.
Publicado: (2011)

The Prognostic Value of UHRF-1 and p53 in Gastric Cancer
por: Babacan, Nalan A., et al.
Publicado: (2016)

Letter regarding “The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis”
por: Jiang, Mingyang, et al.
Publicado: (2019)

Targeting the p53 Pathway in Ewing Sarcoma
por: Neilsen, Paul M., et al.
Publicado: (2011)

Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates
por: Masuda, Yuji, et al.
Publicado: (2019)

Response: Letter regarding “The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis”
por: Sand, Freja Lærke, et al.
Publicado: (2019)

Knockdown of IARS2 Inhibited Proliferation of Acute Myeloid Leukemia Cells by Regulating p53/p21/PCNA/eIF4E Pathway
por: Li, Hong, et al.
Publicado: (2019)

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
por: Günakan, Emre, et al.
Publicado: (2020)

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers
por: Björk-Eriksson, T, et al.
Publicado: (1999)

Investigation of clinicopathological parameters and expression of COX-2, bcl-2, PCNA, and p53 in primary and recurrent sporadic odontogenic keratocysts
por: Kaczmarzyk, Tomasz, et al.
Publicado: (2018)

Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
por: Sorbye, Sveinung W., et al.
Publicado: (2012)

Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2017)

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
por: Landuzzi, Lorena, et al.
Publicado: (2014)

Proteolysis of Xenopus Cip-type CDK inhibitor, p16(Xic2), is regulated by PCNA binding and CDK2 phosphorylation
por: Zhu, Xi-Ning, et al.
Publicado: (2013)

p15(PAF) binding to PCNA modulates the DNA sliding surface
por: De March, Matteo, et al.
Publicado: (2018)

CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
por: Mansilla, Sabrina Florencia, et al.
Publicado: (2020)

p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016)

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer
por: Descamps, Géraldine, et al.
Publicado: (2022)

Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
por: Bian, Chunan, et al.
Publicado: (2015)

Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma
por: Plath, Michaela, et al.
Publicado: (2018)

Correction: Prognostic and clinicopathological value of p53 expression in renal cell carcinoma: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
por: Lipponen, P. K., et al.
Publicado: (1992)

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
por: Bai, Xianguang, et al.
Publicado: (2018)

p53 mutations have no additional prognostic value over stage in bladder cancer.
por: Vet, J. A., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_2dr248uk2kggusucnsr5bbla89